Risks of Antibiotic Exposures Early in Life on the Developing Microbiome

article has not abstract

Vyšlo v časopise: Risks of Antibiotic Exposures Early in Life on the Developing Microbiome. PLoS Pathog 11(7): e32767. doi:10.1371/journal.ppat.1004903
Kategorie: Pearls
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004903

Souhrn

article has not abstract

Zdroje

1. Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R (2011) Development of the Human Gastrointestinal Microbiota and Insights From High-Throughput Sequencing. Gastroenterology 140: 1713–1719. doi: 10.1053/j.gastro.2011.02.011 21530737

2. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. (2011) Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 108: 4578–4585. doi: 10.1073/pnas.1000081107 20668239

3. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. (2012) Human gut microbiome viewed across age and geography. Nature 486: 222–228. doi: 10.1038/nature11053 22699611

4. Zeissig S, Blumberg RS (2014) Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease. Nat Immunol 15: 307–310. doi: 10.1038/ni.2847 24646587

5. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, et al. (2014) Human Genetics Shape the Gut Microbiome. Cell 159: 789–799. doi: 10.1016/j.cell.2014.09.053 25417156

6. Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing. PLoS Biol 6: e280. doi: 10.1371/journal.pbio.0060280 19018661

7. Dethlefsen L, Relman DA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108: 4554–4561. doi: 10.1073/pnas.1000087107 20847294

8. Jernberg C, Löfmark S, Edlund C, Jansson JK (2007) Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1: 56–66. 18043614

9. Antunes LCM, Han J, Ferreira RBR, Lolic P, Borchers CH, Finlay BB (2011) Effect of Antibiotic Treatment on the Intestinal Metabolome. Antimicrob Agents Chemother 55: 1494–1503. doi: 10.1128/AAC.01664-10 21282433

10. Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, et al. (2014) Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences. Cell 158: 705–721. doi: 10.1016/j.cell.2014.05.052 25126780

11. Cahenzli J, Köller Y, Wyss M, Geuking MB, McCoy KD (2013) Intestinal Microbial Diversity during Early-Life Colonization Shapes Long-Term IgE Levels. Cell Host Microbe 14: 559–570. doi: 10.1016/j.chom.2013.10.004 24237701

12. Jakobsson HE, Jernberg C, Andersson AF, Sjölund-Karlsson M, Jansson JK, Engstrand L (2010) Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome. PLoS One 5:e9836. doi: 10.1371/journal.pone.0009836 20352091

13. Kamada N, Núñez G (2014) Regulation of the Immune System by the Resident Intestinal Bacteria. Gastroenterology 146: 1477–1488. doi: 10.1053/j.gastro.2014.01.060 24503128

14. Kamada N, Seo SU, Chen GY, Núñez G (2013) Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol, 13: 321–335. doi: 10.1038/nri3430 23618829

15. Gevers D, Kugathasan S, Denson LA, Vázquez-Baeza Y, Van Treuren W, Ren B, et al. (2014) The Treatment-Naive Microbiome in New-Onset Crohn's Disease. Cell Host Microbe 15: 382–392. doi: 10.1016/j.chom.2014.02.005 24629344

16. Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV, Tysk C, et al. (2013) Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 62: 630–649. doi: 10.1136/gutjnl-2012-303661 23335431

17. Boursi B, Mamtani R, Haynes K, Yang Y (2015) The effect of past antibiotic exposure on diabetes risk. Eur J Endocrinol.

18. Murk W, Risnes KR, Bracken MB (2011) Prenatal or Early-Life Exposure to Antibiotics and Risk of Childhood Asthma: A Systematic Review. Pediatrics 127: 1125–1138. doi: 10.1542/peds.2010-2092 21606151

19. Norgaard M, Nielsen RB, Jacobsen JB, Gradus JL, Stenager E, Koch-Henriksen N, et al. (2011) Use of Penicillin and Other Antibiotics and Risk of Multiple Sclerosis: A Population-based Case-Control Study. Am J Epidemiol 174: 945–948. doi: 10.1093/aje/kwr201 21920946

20. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ (2012) Infant antibiotic exposures and early-life body mass. Int J Obes 37: 16–23.

21. Theriot CM, Koenigsknecht MJ, Carlson PE, Hatton GE, Nelson AM, Li B, et al. (2014) Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 5:3114. doi: 10.1038/ncomms4114 24445449

22. Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, et al. (2012) Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection. Am J Gastroenterol 107:1079–1087. doi: 10.1038/ajg.2012.60 22450732

23. Serino M, Blasco-Baque V, Nicolas S, Burcelin R (2014) Managing the manager: Gut microbes, stem cells and metabolism. Diabetes Metab 40: 186–190. doi: 10.1016/j.diabet.2013.12.004 24462190

24. Foster JA, Neufeld KAM (2013) Gut–brain axis: how the microbiome influences anxiety and depression. Trends in Neurosciences 36: 305–312. doi: 10.1016/j.tins.2013.01.005 23384445